Literature DB >> 6312871

Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia.

R J Klein, A E Friedman-Kien, E DeStefano.   

Abstract

Exposing explant cultures of latently infected mouse trigeminal ganglia alternately to acyclovir-containing and drug-free medium led to a significant decrease in the proportion of ganglia containing reactivatable herpes simplex virus. The loss of virus from the explant cultures was not caused by thermal inactivation during prolonged incubation periods. The efficiency of virus elimination may depend on the frequency and duration of the alternating treatment and on the number of latently infected neurons in the ganglia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312871      PMCID: PMC185116          DOI: 10.1128/AAC.24.1.129

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.

Authors:  R J Klein; E DeStefano; A E Friedman-Kien; E Brady
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 2.  Recurrent herpes simplex: the outlook for systemic antiviral agents.

Authors:  H J Field; P Wildy
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

3.  Ganglionic herpes simplex and systemic acyclovir.

Authors:  D Pavan-Langston; N H Park; M Hettinger
Journal:  Arch Ophthalmol       Date:  1981-08

4.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

5.  Latency competence of thirteen HSV-1 temperature-sensitive mutants.

Authors:  K Watson; J G Stevens; M L Cook; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1980-07       Impact factor: 3.891

6.  Effect of acyclovir on recurrence of herpes simplex skin lesions in mice.

Authors:  W A Blyth; D A Harbour; T J Hill
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

7.  Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.

Authors:  M D Trousdale; E C Dunkel; A B Nesburn
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-11       Impact factor: 4.799

8.  Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.

Authors:  B Svennerholm; A Vahlne; E Lycke
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

9.  Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.

Authors:  H J Field; E De Clercq
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.

Authors:  H J Field; S E Bell; G B Elion; A A Nash; P Wildy
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

View more
  4 in total

1.  Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.

Authors:  J Piret; J Lamontagne; A Désormeaux; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.

Authors:  A M Thackray; H J Field
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on the acute local phase of herpes simplex virus-induced skin infections in mice and the establishment of latency.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 4.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.